These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws. Oreadi D; Papageorge MB J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801 [No Abstract] [Full Text] [Related]
4. Osteonecrosis of the jaw. Reilly MM; Moore S Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):39-41. PubMed ID: 18431898 [No Abstract] [Full Text] [Related]
5. Osteonecrosis or metastases of the jaw or both? Case report and review of the literature. Otto S; Schuler K; Ihrler S; Ehrenfeld M; Mast G J Oral Maxillofac Surg; 2010 May; 68(5):1185-8. PubMed ID: 20144499 [No Abstract] [Full Text] [Related]
6. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases. Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949 [No Abstract] [Full Text] [Related]
7. Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: a clinical report. Göllner M; Holst S; Fenner M; Schmitt J J Prosthet Dent; 2010 Apr; 103(4):196-201. PubMed ID: 20362762 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene. Vairaktaris E; Vassiliou S; Avgoustidis D; Stathopoulos P; Toyoshima T; Yapijakis C J Oral Maxillofac Surg; 2009 Sep; 67(9):2009-12. PubMed ID: 19686941 [No Abstract] [Full Text] [Related]
9. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. Frei M; Bornstein MM; Schaller B; Reichart PA; Weimann R; Iizuka T J Oral Maxillofac Surg; 2010 Apr; 68(4):863-7. PubMed ID: 20307770 [No Abstract] [Full Text] [Related]
10. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws. Gallego L; Junquera L Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371 [TBL] [Abstract][Full Text] [Related]
11. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases. Smith A; Kressley A; Saif MW JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122 [No Abstract] [Full Text] [Related]
12. Nonhealing extraction site. Philipone E Gen Dent; 2005; 53(2):161, 163. PubMed ID: 15833019 [No Abstract] [Full Text] [Related]
13. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222 [No Abstract] [Full Text] [Related]
14. Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw. Wilde F; Hendricks J; Riese C; Pausch NC; Schramm A; Heufelder M J Oral Maxillofac Surg; 2011 Oct; 69(10):2657-62. PubMed ID: 21741741 [No Abstract] [Full Text] [Related]